NO20060781L - Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser - Google Patents

Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser

Info

Publication number
NO20060781L
NO20060781L NO20060781A NO20060781A NO20060781L NO 20060781 L NO20060781 L NO 20060781L NO 20060781 A NO20060781 A NO 20060781A NO 20060781 A NO20060781 A NO 20060781A NO 20060781 L NO20060781 L NO 20060781L
Authority
NO
Norway
Prior art keywords
inflammatory
autoimmune disorders
soluble
human
treatment
Prior art date
Application number
NO20060781A
Other languages
English (en)
Norwegian (no)
Inventor
Yolande Chvatchko
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20060781L publication Critical patent/NO20060781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20060781A 2003-07-23 2006-02-17 Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser NO20060781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077316 2003-07-23
PCT/EP2004/051596 WO2005011728A2 (fr) 2003-07-23 2004-07-23 Utilisation de cd164 soluble pour les troubles inflammatoires ou auto-immuns

Publications (1)

Publication Number Publication Date
NO20060781L true NO20060781L (no) 2006-03-17

Family

ID=34112463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060781A NO20060781L (no) 2003-07-23 2006-02-17 Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser

Country Status (15)

Country Link
US (2) US20060257402A1 (fr)
EP (1) EP1646396A2 (fr)
JP (1) JP4705028B2 (fr)
KR (1) KR20060106810A (fr)
CN (1) CN1845752A (fr)
AR (1) AR045074A1 (fr)
AU (1) AU2004260835A1 (fr)
BR (1) BRPI0412243A (fr)
CA (1) CA2532870A1 (fr)
EA (1) EA009389B1 (fr)
IL (1) IL173197A0 (fr)
NO (1) NO20060781L (fr)
RS (1) RS20060023A (fr)
WO (1) WO2005011728A2 (fr)
ZA (1) ZA200600193B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008527986A (ja) 2005-01-24 2008-07-31 ラボラトワール セローノ ソシエテ アノニム 炎症及び／又は自己免疫疾患における可溶性ｃｄ１６４の使用
NZ578077A (en) 2007-02-12 2012-04-27 Stefan Hansson Diagnosis of preeclampsia using free foetal haemoglobin
ES2571956T3 (es) 2008-07-18 2016-05-27 A1M Pharma Ab Uso médico de la alfa 1-microglobulina antioxidante y eliminadora de radicales
US8392585B1 (en) * 2011-09-26 2013-03-05 Theranos, Inc. Methods and systems for facilitating network connectivity
WO2022099695A1 (fr) * 2020-11-16 2022-05-19 Jiangsu Cell Tech Medical Research Institute Co., Ltd. Fusion cd164 et leurs utilisations
CN114891107A (zh) * 2022-05-12 2022-08-12 北京农学院 一种抗猪cd164l2单克隆抗体制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296792A1 (fr) * 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
EP1409536A2 (fr) * 2001-02-12 2004-04-21 Curagen Corporation Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines

Also Published As

Publication number Publication date
BRPI0412243A (pt) 2006-09-19
EA200600314A1 (ru) 2006-06-30
RS20060023A (en) 2008-06-05
AR045074A1 (es) 2005-10-12
ZA200600193B (en) 2007-04-25
US20090285838A1 (en) 2009-11-19
US8075894B2 (en) 2011-12-13
CN1845752A (zh) 2006-10-11
WO2005011728A3 (fr) 2005-06-02
US20060257402A1 (en) 2006-11-16
EA009389B1 (ru) 2007-12-28
IL173197A0 (en) 2006-06-11
KR20060106810A (ko) 2006-10-12
JP2006528159A (ja) 2006-12-14
WO2005011728A2 (fr) 2005-02-10
AU2004260835A1 (en) 2005-02-10
EP1646396A2 (fr) 2006-04-19
CA2532870A1 (fr) 2005-02-10
JP4705028B2 (ja) 2011-06-22

Similar Documents

Publication Publication Date Title
BR0214309A (pt) Derivados aril-1,4-pirazina substituìdos
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20055741D0 (no) Nye kjemiske forbindelser
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
TW200732347A (en) VEGF analogs and methods of use
NO20061736L (no) Krystallform av epotilon B
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
WO2006121610A3 (fr) Compositions de soins personnels et methodes d'utilisation
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
ATE448232T1 (de) Substituierte heterozyklen
TNSN07036A1 (en) Human monoclonal antibodies against human il-4
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
WO2004031129A3 (fr) Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus
DK2380583T3 (da) Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser
AU2002338852A1 (en) Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
SE0302304D0 (sv) Novel compounds
NO20053903L (no) Nukleotidlipidesterderivater.
NO20060420L (no) 2-aminobenzoylderivater
CY1106409T1 (el) Παραγωγα κινολινης
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO

FC2A Withdrawal, rejection or dismissal of laid open patent application